Onpattro Market Report 2025-2034: Industry Overview, Trends, And Forecast Analysis

The Onpattro Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Current Onpattro Market Size and Its Estimated Growth Rate?
The market size of onpattro, which has seen a XX (HCAGR) lately, is poised to expand from $XX million in 2024 to $XX million in 2025, registering a compound annual growth rate (CAGR) of XX%. This growth experienced in the historical period can be traced back to the increasing occurrence of hereditary transthyretin-mediated amyloidosis, heightened consciousness about rare diseases, a surge in research and development funding, an increasing elderly population, and escalating TH*Care costs.

The market size of onpattro is projected to expand at a rate of XX (FCAGR) over the next couple of years. By 2029, it's anticipated to reach a valuation of $XX million, increasing at a Compound Annual Growth Rate (CAGR) of XX%. The growth projected for the forecast period can be credited to factors such as partnerships and licensing, regulatory backing, increasing instances of chronic health conditions, expanding biopharmaceutical partnerships, and a rise in transthyretin amyloidosis cases. Key patterns expected during the forecast period include broader acceptance of ribonucleic acid-based therapies, a surge in orphan drug designations, integration with digital health tools, a shift towards personalised medicine, and advancements in drug delivery technology.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20169

How Are Emerging Segments Shaping the Onpattro Market Landscape?
The onpattro market covered in this report is segmented -

1) By Clinical Indication: Hereditary Transthyretin-Mediated Amyloidosis, Wild-Type Transthyretin Amyloidosis, Other Transthyretin-Related Amyloidoses
2) By Distribution Channel: Direct Sales, Pharmacies, Online Pharmacies
3) By End User: Hospitals, Specialty Clinics, Home TH*Care Providers

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20169&type=smp

Which Growth Factors Are Influencing Onpattro Market Expansion?
The increasing occurrence of hereditary transthyretin-mediated amyloidosis is anticipated to boost the expansion of the onpattro market in the future. Hereditary transthyretin-mediated amyloidosis (hATTR) is an uncommon genetic disorder in which mutated TTR proteins cause harmful deposits, impacting nerves and the heart. The growth in cases of hereditary transthyretin-mediated amyloidosis is facilitated by improved diagnostic techniques, genetic testing, and raised consciousness. Onpattro is employed to manage hereditary transthyretin-mediated amyloidosis by inhibiting the transthyretin (TTR) gene, reducing the production of the amyloid protein, and preventing organ damage. For example, in February 2024, Verywell Health, a US-based health information platform, stated that hereditary transthyretin-mediated amyloidosis globally impacts 5,500-38,500 people, with estimates in the U.S. ranging from 104 to 3,847 cases of hereditary transthyretin-mediated amyloidosis with polyneuropathy, indicating a significant level of underdiagnosis. As a result, the escalating occurrence of hereditary transthyretin-mediated amyloidosis promotes the onpattro market's growth.

Who Are the Dominant Players Across Different Onpattro Market Segments?
Major companies operating in the onpattro market include Alnylam Pharmaceuticals Inc.

What Are the Latest Developing Trends in the Adcetris Market?
The main trend in the Onpattro market revolves around increasing the indications of the drug through supplemental drug applications. This strategy aims to enhance its market potential and cater to a broader spectrum of patient needs. Normally, supplemental drug applications aim to increase the approved uses of a drug, which may mean targeting new indications, patient groups, or even different formulations, essentially expanding its curative scope and market possibility. For example, in February 2023, Alnylam Pharmaceuticals, an American pharmaceutical corporation, formally declared the acceptance of a Supplemental New Drug Application (sNDA) for ONPATTRO (patisiran). The treatment is designed to combat cardiomyopathy that is linked to transthyretin amyloidosis (ATTR). ONPATTRO is an RNA interference (RNAi) therapeutic which is designed to specifically target the transthyretin (TTR) protein that abnormally accumulates in patients with ATTR amyloidosis, causing severe complications like cardiomyopathy. Initially, the drug was approved in 2018 for the treatment of polyneuropathy tied to hereditary ATTR amyloidosis. The recent sNDA application was made based on data from the Phase III APOLLO-B study, which showed that patisiran had a noteworthy improvement in functional ability and quality of life in patients with cardiomyopathy compared to a placebo.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/onpattro-global-market-report

Which Geographic Regions Are Expected to Dominate the Onpattro Market in the Coming Years?
North America was the largest region in the onpattro market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the onpattro market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Onpattro Market?
2. What is the CAGR expected in the Onpattro Market?
3. What Are the Key Innovations Transforming the Onpattro Industry?
4. Which Region Is Leading the Onpattro Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.